Home - The Dermatology Digest

Advertisement

From the Podium to Your Practice: Dr. Christopher Bunick Discusses New Real-world Safety Data on Upadacitinib (Rinvoq, AbbVie) in AD

September 19, 2025

Breaking News: U.S. FDA Approves Ruxolitinib Cream 1.5% (Opzelura, Incyte) for Kids Age 2 and up With AD

September 18, 2025

Study Validates Nicotinamide’s Role in Skin Cancer Chemoprevention

September 18, 2025

Battle of the PsO Pills: Investigational Icotrokinra Bests Deucravacitinib (Sotyktu, BMS) in Phase 3 Trials

September 18, 2025

AD Pipeline Watch: Rezpegaldesleukin Hits Primary and Key Secondary Endpoints in REZOLVE-AD Phase 2b Study

September 18, 2025

Hot Drop Alert: Cetaphil’s New Skin Activator Hydrating & Firming Line Launches in Partnership With Actress Mariska Hargitay

September 18, 2025

Advertisement

Advertisement

Latest Issue

Latest Supplements

Upcoming Conferences

Advertisement

Advertisement

Digital Edition Archive